Pulse Biosciences, Inc.
PLSE
Rang in Aktien
#4269
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Aktienkurs
$51.39
Zuletzt synchronisiert: 2026-10-21
Marktkapitalisierung
$3.67B
Veränderung (1 Tag)
1.09%
Veränderung (1 Jahr)
197.94%
Land
US
Handel Pulse Biosciences, Inc. (PLSE)
Kategorie
Healthcare
Kursverlauf für Pulse Biosciences, Inc. (PLSE)
Höchster Schlusskurs: $49.20 am 2026-10-01
Niedrigster Schlusskurs: $4.20 am 2016-05-01
Niedrigster Schlusskurs: $4.20 am 2016-05-01
Kursverlauf der Aktie von Pulse Biosciences, Inc. von 2016 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | 90.82% |
| 2025 | -23.80% |
| 2024 | 72.60% |
| 2023 | 322.28% |
| 2022 | -84.88% |
| 2021 | -15.48% |
| 2020 | 41.40% |
| 2019 | 19.04% |
| 2018 | -50.17% |
| 2017 | 306.74% |
| 2016 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $431.34 | -18.16% |
US
|
|
| $194.56 | -46.20% |
FR
|
|
| $170.48 | 12.48% |
JP
|
|
| $194.26 | 31.35% |
US
|
|
| $67.86 | -11.34% |
CH
|
